Literature DB >> 17933425

Cocaine, myocardial infarction, and beta-blockers: time to rethink the equation?

Kalev Freeman, James A Feldman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17933425     DOI: 10.1016/j.annemergmed.2007.08.020

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


× No keyword cloud information.
  6 in total

Review 1.  Sympathomimetic Toxidromes and Other Pharmacological Causes of Acute Hypertension.

Authors:  Andrew King; Mirjana Dimovska; Luke Bisoski
Journal:  Curr Hypertens Rep       Date:  2018-02-24       Impact factor: 5.369

2.  Clinical features and outcomes between African American and Caucasian patients with Takotsubo Syndrome.

Authors:  Krishna Ravindra; Marco G Del Buono; Juan G Chiabrando; Peter Westman; Edoardo Bressi; Dinesh Kadariya; Curtis Maehara; Megan Dell; Liangsuo Ma; Jessie VAN Wezenbeek; F Gerard Moeller; Lori Keyser-Marcus; Larry D Keen; Tamas S Gal; Antonio Abbate
Journal:  Minerva Cardiol Angiol       Date:  2021-01-11

3.  Early use of beta blockers in patients with cocaine associated chest pain.

Authors:  Christian Espana Schmidt; Luciano Pastori; Gerald Pekler; Ferdinand Visco; Savi Mushiyev
Journal:  Int J Cardiol Heart Vasc       Date:  2015-06-14

Review 4.  The clinical toxicology of caffeine: A review and case study.

Authors:  Cyril Willson
Journal:  Toxicol Rep       Date:  2018-11-03

Review 5.  Sympathomimetic amine compounds and hepatotoxicity: Not all are alike-Key distinctions noted in a short review.

Authors:  Cyril Willson
Journal:  Toxicol Rep       Date:  2018-12-01

6.  In-Hospital and Long-Term Outcomes of Beta-Blocker Treatment in Cocaine Users: A Systematic Review and Meta-analysis.

Authors:  Doosup Shin; Eun Sun Lee; Chandrashekar Bohra; Kullatham Kongpakpaisarn
Journal:  Cardiol Res       Date:  2019-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.